UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation

Background: Linaclotide, a guanylate cyclase C agonist, has been shown in clinical trials to improve symptoms of irritable bowel syndrome with constipation (IBS-C). Here we report data from a real-world study of linaclotide in the UK. Methods: This 1-year, multicentre, prospective, observational stu...

Полное описание

Библиографические подробности

Главные авторы:	Yan Yiannakou, Anu Agrawal, Patrick B. Allen, Naila Arebi, Steven R. Brown, Maria P. Eugenicos, Adam D. Farmer, Su McLain-Smith, John McLaughlin, David S. Sanders, Dominic Lawrance, Anton Emmanuel
Формат:	Artigo
Язык:	Inglês
Опубликовано:	SAGE Publishing 2018-09-01
Серии:	Therapeutic Advances in Gastroenterology
Online-ссылка:	https://doi.org/10.1177/1756284818798791
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!